SlideShare a Scribd company logo
1 of 39
6/6/2022
K.G.M.U (CON)
1
PRESENTED BY
SWATI RAI
M.Sc. NURSING 1st YEAR
6/6/2022
K.G.M.U (CON) SARCOMA
2
OUTLINE
6/6/2022
K.G.M.U (CON) SARCOMA
3
After completion of the practice teaching the
participants will be able to :
 Introduction
 Definition of Sarcoma
 Incidence
 Types of sarcoma
 Etiology
 Clinical manifestation
Contd.
6/6/2022
K.G.M.U (CON) SARCOMA
4
 Pathophysiology of sarcoma
 Assessment and diagnostic evaluation
 Medical management (Pharmacological and Non –
Pharmacological)
 Surgical management
 Nursing management
 Complications
 Health education
Q.1 WHAT IS CANCER ?
Q.2 WORLD CANCER DAY IS CELEBRATED ON ?
6/6/2022
K.G.M.U (CON) SARCOMA
5
INTRODUCTION
6/6/2022
K.G.M.U (CON) SARCOMA
6
 SARCOMA –
A rare type of cancer that grow
in connective tissue like bones, nerves, muscles, and
blood vessels of the arms and legs. It causes abdominal
pain, lump, bone pain, and weight loss.
Soft tissue sarcoma forms in the tissues that connect,
support and surround other body structures.
DEFINITION
6/6/2022
K.G.M.U (CON) SARCOMA
7
 Sarcoma is a type of cancer that can occur in various
locations in your body. Sarcoma is the general term for a
broad group of cancers that begin in the bones also
known as (soft tissue sarcoma).
CLASSIFICATION OF
TUMORS
6/6/2022
K.G.M.U (CON) SARCOMA
8
INCIDENCE
6/6/2022
K.G.M.U (CON) SARCOMA
9
 The incidence for all ages is one case per 1
million people in the United States. In patients aged 10 to
19 years, the incidence is between nine and ten cases per
1 million people.
TYPES OF CANCER
6/6/2022
K.G.M.U (CON) SARCOMA
10
 Benign tumors- are slow growing tumors, well
circumscribed, and encapusulated. They produce few
symptoms . Benign primary neoplasms of
musculoskeletal system.
 Malignant benign tumor – primary malignant tumor
are relatively rare and arise from connective tissues
cells or bone marrow elements (myelomas).
 Metastatic tumor – more common malignant bone
tumor.the most common primary sites of tumors that
metastasize to bone are kidney.
TYPES OF SARCOMA
6/6/2022
K.G.M.U (CON) SARCOMA
11
ETIOLOGY
6/6/2022
K.G.M.U (CON) SARCOMA
12
 Growth related : risk is highest for
those between 10-30yrs of age .the
risk goes down during in middle age
but rises in older age of 60’s .
 Somatic alterations : TP53 AND
RB1 shows recurrent somatic
alterations in concurrent studies .
 Radiation therapy for cancer-
Radiation treatment for cancer
increases the risk of developing a
sarcoma later.
Contd.
6/6/2022
K.G.M.U (CON) SARCOMA
13
 Exposure to chemicals. Certain chemicals, such as some
industrial chemicals and herbicides, can increase the risk
of sarcoma that affects the liver.
 Exposure to viruses. The virus called humanherpesvirus
8 can increase the risk of a type of sarcoma called
Kaposi's sarcoma in people with weakened immune
systems.
6/6/2022
K.G.M.U (CON) SARCOMA
14
 Germ line defect :
The tumors is identified by the tissue of origin , the
anatomic site, the behaviour the tumors(benign or
malignant ).
 EMBRYONAL ECTODERM - originates Carcinoma
(skin and glands ).
 ENDODERM – Mucus membrane linings of respiratory
tract , GI , GU tract.
 MESODERM –sarcoma(connective tissue, muscles, bone
and fat ).
 Lymphoma and leukemia are originated from
HEMATOPOETIC SYSTEM .
Contd.
CANCER PATHOPHYSIOLOGY
6/6/2022
K.G.M.U (CON) SARCOMA
15
PATHOPHYSIOLOGY
6/6/2022
K.G.M.U (CON) SARCOMA
16
6/6/2022
K.G.M.U (CON) SARCOMA
17
SIGN AND SYMPTOMS
6/6/2022
K.G.M.U (CON) SARCOMA
18
 A lump that can be felt through the skin that may or may
not be painful
 Bone pain
 Joint swelling and stiffness
 Weight loss
 Spinal metastasis resulting in cord compression and
neurologic deficits, paresthesia, paraplegia .
 Abdominal pain (due to abdominal metastasis and have
poor prognosis)
DIAGNOSTIC EVALUATION
6/6/2022
K.G.M.U (CON) SARCOMA
19
 Collect the history upto 3rd gen. and perform a physical
examination , may be diagnosed incidentally after
pathologic fracture.
 Inspection, palpation can be done to identify the lump or
mass .
 Perform ct scan , bone scans , myelography, MRI, and
chest x ray.
 Obtain biochemical assay of the blood to identify TP53
and RB1 gene .
 Alkaline phosphate levels are frequently elevated with
osteogenic sarcoma , serum acid phosphate levels are
elevated with metastasis in liver .
6/6/2022
K.G.M.U (CON) SARCOMA
20
 Arteriography – to assess the soft
tissue involvement. x-ray
examination of an artery or arteries
following injection of a radiopaque
substance.{Barium sulfate and
organic iodides} are commonly used .
 Improve the image contrast
(radiocontrast) and visibility of
relevant anatomic loci.
6/6/2022
K.G.M.U (CON) SARCOMA
21
 Perform surgical biopsy for histologic identification ,
staging, based on tumor size, grade ,location and
metastasis. (TNM classification )
 BIOPSY :
 FINE NEEDLE ASPIRATION CYTOLOGY (FNAC )
 CORE NEDDLE ASPIRATION (CNA)
BIOPSY
6/6/2022
K.G.M.U (CON) SARCOMA
22
MANAGEMENT MODALITY
6/6/2022
K.G.M.U (CON) SARCOMA
23
CHEMOTHERAPY
6/6/2022
K.G.M.U (CON) SARCOMA
24
 Chemotherapy is started before and continued after
surgery in an effort to eradicate micrometastatic lesions.
 Drugs : MAID REGIMEN [ Mesna,
Adriyamycin(doxorubicin), Ifofosfamide and
Dacarbazine]
 AID RGIMEN- Adriyamycin, Ifofosfamide , Mesna
SURGICAL MANAGEMENT
6/6/2022
K.G.M.U (CON) SARCOMA
25
 LIMB SALVAGE : – involves resection, of affected
bone , muscle and normal muscle tissue and
reconstruction using metallic prosthesis or allografts for
bone or joint replacement and skin grafting as needed.
6/6/2022
K.G.M.U (CON) SARCOMA
26
 Radiation is energy that is
emitted from a source and
travels through space or
some material .
 Delivery of high- energy
beams when absorbed into
tissue ,produces ionization
radiation act to break the
chemical bond in DNA .
 The DNA is damaged,
resulting in cell death .
 TYPES OF IONIZING
RADIATION
RADIATION THERAPY
1. Electromagnetic
radiation i.e ( x -
ray , gamma ray )
2.Particulate
radiation (alpha
particles,electrons,
neutrons, protons)
3.High – energy - x
rays (photons)
RADIATION THERAPY
6/6/2022
K.G.M.U (CON) SARCOMA
27
COMPLICATIONS
6/6/2022
K.G.M.U (CON) SARCOMA
28
 Metastasis.
 Pathologic fracture
 Hypercalcemia from bone destruction
NURSING MANAGEMENT
6/6/2022
K.G.M.U (CON) SARCOMA
29
ASSESSMENT
 Obtain the health history of progression of
disease , presence of pain ,fever ,weight loss
and malaise .
 Examine for painless mass .
 Review records for evidence of pathologic
fractures .
 Asses knowledge of cancer experiences with
family , others, and present coping .
NURSING DIAGNOSIS
6/6/2022
K.G.M.U (CON) SARCOMA
30
1. Acute pain related to effects of tumors .
2. Risk for injury related to altered bone structure
3. Ineffective coping related to diagnosis and treatment
options.
4. Altered Nutrition: Less Than Body Requirements related
to hypermetabolic state associated with
cancer/Consequences of chemotherapy, radiation,
surgery, e.g., anorexia,
5. Risk for Infection related to Inadequate secondary
defences and immuno suppression, e.g., bone marrow
suppression
NURSING INTERVENTION
6/6/2022
K.G.M.U (CON) SARCOMA
31
 Acute pain related to effects of tumors
 Use multiple approaches to reduce discomfort
 Administer pain medication 30 minutes before
ambulation or other uncomfortable movement .
 Support painful extrimities on pillows.
 Risk for injury related to altered bone structure
 Assist patients in movement with gentleness and patience
 Avoid jarring patients and bed .
 Supports joints when repositioning patients.
6/6/2022
K.G.M.U (CON) SARCOMA
32
 Guard patients to avoid falls raise the side rails .
 Create a hazard –free environment .
 Provide patients education on safety and ambulation
 Ineffective coping related to diagnosis and treatment
options.
 Create a supportive environment
 Answer questions and clear up misconceptions about
treatment options .
 Use pshychological support services as nedded
PATIENT EDUCATION AND
HEALTH MAINTENANCE
6/6/2022
K.G.M.U (CON) SARCOMA
33
 Teach about particular treatment selected .
 Encourage appropriate follow up and diagnostic
testing for recurrence.
 Refer for additional information and support to the
American cancer society .
PROGNOSIS
6/6/2022
K.G.M.U (CON) SARCOMA
34
 Using the SEER database, statistics show that people with
a soft tissue sarcoma have an average 5-year survival rate
of 65%.
 Sarcoma life expectancy depends on factors such as the
tumor’s type, size, location, rapidity of tumor cell growth,
and where it is located when first diagnosed.
 The National Cancer Institute reports 5-year survival data
for cancer from the SEER (Surveillance, Epidemiology
and End Results) database, based on whether the cancer
was found when it hadn’t yet spread (localized) .
6/6/2022
K.G.M.U (CON) SARCOMA
35
RECAPTUALIZATION
6/6/2022
K.G.M.U (CON) SARCOMA
36
1. Which one of the following soft tissue sarcomas frequently metastasizes
to lymph nodes?
A. Fibrosarcoma
B. Alveolar soft part sarcoma
C. Osteosarcoma
D. Embryonal Rhabdomyosarcoma
Answer - D
2. Which type of cancer is sarcoma ?
A. A sarcoma is same as carcinoma but is benign
B. A sarcoma is a cancer that develops from tissue like the muscle .
C. A sarcoma is a type of cancer that does not spread to other sites.
D. A sarcoma affects only children while a carcinoma affect only adults
Answer - B
6/6/2022
K.G.M.U (CON) SARCOMA
37
3. A sarcoma that arise from fat tissue is called –
A. Fibrosarcoma
B. Liposarcoma
C. Leimyosarcoma
D. Rhabdomyosarcoma
Answer - B
4. Osteosarcoma arise from the
A. Muscle
B. Bone
C. Blood vessels
D. Nerves
Answer - B
ASSIGNMENT
6/6/2022
K.G.M.U (CON) SARCOMA
38
 Write a short note on sarcoma and its management ?
 Date of submission : 07/06/2022
6/6/2022
K.G.M.U (CON) SARCOMA
39

More Related Content

What's hot (20)

Hernia
HerniaHernia
Hernia
 
Exstrophy of bladder
Exstrophy of  bladder Exstrophy of  bladder
Exstrophy of bladder
 
Intestinal obstruction
Intestinal  obstructionIntestinal  obstruction
Intestinal obstruction
 
Gastric cancer
Gastric cancerGastric cancer
Gastric cancer
 
Cirrhosis of liver
Cirrhosis of liverCirrhosis of liver
Cirrhosis of liver
 
Hypospadias & epispadias
Hypospadias &  epispadiasHypospadias &  epispadias
Hypospadias & epispadias
 
Benign prostatic hyperplasia (BPH)
Benign prostatic hyperplasia (BPH)Benign prostatic hyperplasia (BPH)
Benign prostatic hyperplasia (BPH)
 
What is Dumping Syndrome?
What is Dumping Syndrome?What is Dumping Syndrome?
What is Dumping Syndrome?
 
Intestinal obstruction with Nursing Management
Intestinal obstruction with Nursing ManagementIntestinal obstruction with Nursing Management
Intestinal obstruction with Nursing Management
 
Gastric cancer
Gastric cancerGastric cancer
Gastric cancer
 
Appendicitis
AppendicitisAppendicitis
Appendicitis
 
Ureteral stricture
Ureteral strictureUreteral stricture
Ureteral stricture
 
Liver cancer
Liver cancerLiver cancer
Liver cancer
 
Gastric Cancer PPT
Gastric Cancer PPTGastric Cancer PPT
Gastric Cancer PPT
 
Hiatal hernia
Hiatal hernia Hiatal hernia
Hiatal hernia
 
Hypospadias ppt
Hypospadias pptHypospadias ppt
Hypospadias ppt
 
Surgical Management of Intestinal Obstruction
Surgical Management of Intestinal Obstruction Surgical Management of Intestinal Obstruction
Surgical Management of Intestinal Obstruction
 
Intestinal obstruction
Intestinal obstructionIntestinal obstruction
Intestinal obstruction
 
Stomach cancer
Stomach cancerStomach cancer
Stomach cancer
 
Gynecomastia
GynecomastiaGynecomastia
Gynecomastia
 

Similar to SARCOMA.pptx

MANAGEMENT OF MENINGIOMA
MANAGEMENT OF MENINGIOMAMANAGEMENT OF MENINGIOMA
MANAGEMENT OF MENINGIOMAKanhu Charan
 
Dr Adeola Henry_Colorectal cancer book chapter 2014
Dr Adeola Henry_Colorectal cancer book chapter 2014Dr Adeola Henry_Colorectal cancer book chapter 2014
Dr Adeola Henry_Colorectal cancer book chapter 2014adeolahenry
 
The effect of microgravity on cell death, cell growth and cell cycle on breas...
The effect of microgravity on cell death, cell growth and cell cycle on breas...The effect of microgravity on cell death, cell growth and cell cycle on breas...
The effect of microgravity on cell death, cell growth and cell cycle on breas...Journal of Research in Biology
 
The effect of microgravity on cell death, cell growth and cell cycle on breas...
The effect of microgravity on cell death, cell growth and cell cycle on breas...The effect of microgravity on cell death, cell growth and cell cycle on breas...
The effect of microgravity on cell death, cell growth and cell cycle on breas...Journal of Research in Biology
 
Comparison of risk factors and molecular analysis of right-sided colon and le...
Comparison of risk factors and molecular analysis of right-sided colon and le...Comparison of risk factors and molecular analysis of right-sided colon and le...
Comparison of risk factors and molecular analysis of right-sided colon and le...M. Luisetto Pharm.D.Spec. Pharmacology
 
SEP 2023 ONCOLOGY CARTOONS
SEP 2023 ONCOLOGY CARTOONSSEP 2023 ONCOLOGY CARTOONS
SEP 2023 ONCOLOGY CARTOONSKanhu Charan
 
JUNE 2023 ONCOLOGY CARTOONS
JUNE 2023 ONCOLOGY CARTOONSJUNE 2023 ONCOLOGY CARTOONS
JUNE 2023 ONCOLOGY CARTOONSKanhu Charan
 
MiRNAs as novel biomarkers for dysplsia in IBD associated cancer
MiRNAs as novel biomarkers for dysplsia in IBD associated cancerMiRNAs as novel biomarkers for dysplsia in IBD associated cancer
MiRNAs as novel biomarkers for dysplsia in IBD associated cancerGerhard Jung, MD, PhD
 
Web cast cancer gene panels march 11 2015
Web cast cancer gene panels march 11 2015Web cast cancer gene panels march 11 2015
Web cast cancer gene panels march 11 2015Andreas Scherer
 
Cancer Gene Panels
Cancer Gene PanelsCancer Gene Panels
Cancer Gene PanelsGolden Helix
 
Primary Bone Tumour of the Spine
Primary Bone Tumour of the SpinePrimary Bone Tumour of the Spine
Primary Bone Tumour of the SpineDrMdShafiulAlam
 
Angiosarcoma Review
Angiosarcoma ReviewAngiosarcoma Review
Angiosarcoma ReviewNHS
 
Tumor markers :towards improving the landscape of cancer biomarker research
Tumor markers :towards improving the landscape of cancer biomarker researchTumor markers :towards improving the landscape of cancer biomarker research
Tumor markers :towards improving the landscape of cancer biomarker researchdr_ekbalabohashem
 

Similar to SARCOMA.pptx (20)

H0422050055
H0422050055H0422050055
H0422050055
 
MANAGEMENT OF MENINGIOMA
MANAGEMENT OF MENINGIOMAMANAGEMENT OF MENINGIOMA
MANAGEMENT OF MENINGIOMA
 
Beyond Eye Treatment
Beyond Eye TreatmentBeyond Eye Treatment
Beyond Eye Treatment
 
Dr Adeola Henry_Colorectal cancer book chapter 2014
Dr Adeola Henry_Colorectal cancer book chapter 2014Dr Adeola Henry_Colorectal cancer book chapter 2014
Dr Adeola Henry_Colorectal cancer book chapter 2014
 
CRC CHP final PDF
CRC CHP final PDFCRC CHP final PDF
CRC CHP final PDF
 
The effect of microgravity on cell death, cell growth and cell cycle on breas...
The effect of microgravity on cell death, cell growth and cell cycle on breas...The effect of microgravity on cell death, cell growth and cell cycle on breas...
The effect of microgravity on cell death, cell growth and cell cycle on breas...
 
The effect of microgravity on cell death, cell growth and cell cycle on breas...
The effect of microgravity on cell death, cell growth and cell cycle on breas...The effect of microgravity on cell death, cell growth and cell cycle on breas...
The effect of microgravity on cell death, cell growth and cell cycle on breas...
 
Comparison of risk factors and molecular analysis of right-sided colon and le...
Comparison of risk factors and molecular analysis of right-sided colon and le...Comparison of risk factors and molecular analysis of right-sided colon and le...
Comparison of risk factors and molecular analysis of right-sided colon and le...
 
SEP 2023 ONCOLOGY CARTOONS
SEP 2023 ONCOLOGY CARTOONSSEP 2023 ONCOLOGY CARTOONS
SEP 2023 ONCOLOGY CARTOONS
 
JUNE 2023 ONCOLOGY CARTOONS
JUNE 2023 ONCOLOGY CARTOONSJUNE 2023 ONCOLOGY CARTOONS
JUNE 2023 ONCOLOGY CARTOONS
 
Molecular imaging – a new field for a new world By Zaver M. Bhujwalla
Molecular imaging – a new field for a new world By Zaver M. BhujwallaMolecular imaging – a new field for a new world By Zaver M. Bhujwalla
Molecular imaging – a new field for a new world By Zaver M. Bhujwalla
 
MiRNAs as novel biomarkers for dysplsia in IBD associated cancer
MiRNAs as novel biomarkers for dysplsia in IBD associated cancerMiRNAs as novel biomarkers for dysplsia in IBD associated cancer
MiRNAs as novel biomarkers for dysplsia in IBD associated cancer
 
10 testicular cancer
10 testicular cancer10 testicular cancer
10 testicular cancer
 
Halliwell et al, 2016
Halliwell et al, 2016Halliwell et al, 2016
Halliwell et al, 2016
 
Web cast cancer gene panels march 11 2015
Web cast cancer gene panels march 11 2015Web cast cancer gene panels march 11 2015
Web cast cancer gene panels march 11 2015
 
Cancer Gene Panels
Cancer Gene PanelsCancer Gene Panels
Cancer Gene Panels
 
U0 vqmt qyodk=
U0 vqmt qyodk=U0 vqmt qyodk=
U0 vqmt qyodk=
 
Primary Bone Tumour of the Spine
Primary Bone Tumour of the SpinePrimary Bone Tumour of the Spine
Primary Bone Tumour of the Spine
 
Angiosarcoma Review
Angiosarcoma ReviewAngiosarcoma Review
Angiosarcoma Review
 
Tumor markers :towards improving the landscape of cancer biomarker research
Tumor markers :towards improving the landscape of cancer biomarker researchTumor markers :towards improving the landscape of cancer biomarker research
Tumor markers :towards improving the landscape of cancer biomarker research
 

Recently uploaded

STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCESTERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCEPRINCE C P
 
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxPhysiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxAArockiyaNisha
 
Presentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxPresentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxgindu3009
 
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Biopesticide (2).pptx  .This slides helps to know the different types of biop...Biopesticide (2).pptx  .This slides helps to know the different types of biop...
Biopesticide (2).pptx .This slides helps to know the different types of biop...RohitNehra6
 
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...jana861314
 
Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Patrick Diehl
 
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bNightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bSérgio Sacani
 
Orientation, design and principles of polyhouse
Orientation, design and principles of polyhouseOrientation, design and principles of polyhouse
Orientation, design and principles of polyhousejana861314
 
GFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxGFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxAleenaTreesaSaji
 
Caco-2 cell permeability assay for drug absorption
Caco-2 cell permeability assay for drug absorptionCaco-2 cell permeability assay for drug absorption
Caco-2 cell permeability assay for drug absorptionPriyansha Singh
 
Biological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfBiological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfmuntazimhurra
 
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxAnalytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxSwapnil Therkar
 
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...anilsa9823
 
A relative description on Sonoporation.pdf
A relative description on Sonoporation.pdfA relative description on Sonoporation.pdf
A relative description on Sonoporation.pdfnehabiju2046
 
Isotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoIsotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoSérgio Sacani
 
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.aasikanpl
 
Work, Energy and Power for class 10 ICSE Physics
Work, Energy and Power for class 10 ICSE PhysicsWork, Energy and Power for class 10 ICSE Physics
Work, Energy and Power for class 10 ICSE Physicsvishikhakeshava1
 

Recently uploaded (20)

STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCESTERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
STERILITY TESTING OF PHARMACEUTICALS ppt by DR.C.P.PRINCE
 
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptxPhysiochemical properties of nanomaterials and its nanotoxicity.pptx
Physiochemical properties of nanomaterials and its nanotoxicity.pptx
 
Presentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptxPresentation Vikram Lander by Vedansh Gupta.pptx
Presentation Vikram Lander by Vedansh Gupta.pptx
 
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Biopesticide (2).pptx  .This slides helps to know the different types of biop...Biopesticide (2).pptx  .This slides helps to know the different types of biop...
Biopesticide (2).pptx .This slides helps to know the different types of biop...
 
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
Traditional Agroforestry System in India- Shifting Cultivation, Taungya, Home...
 
Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?
 
CELL -Structural and Functional unit of life.pdf
CELL -Structural and Functional unit of life.pdfCELL -Structural and Functional unit of life.pdf
CELL -Structural and Functional unit of life.pdf
 
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43bNightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
Nightside clouds and disequilibrium chemistry on the hot Jupiter WASP-43b
 
Orientation, design and principles of polyhouse
Orientation, design and principles of polyhouseOrientation, design and principles of polyhouse
Orientation, design and principles of polyhouse
 
GFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxGFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptx
 
Engler and Prantl system of classification in plant taxonomy
Engler and Prantl system of classification in plant taxonomyEngler and Prantl system of classification in plant taxonomy
Engler and Prantl system of classification in plant taxonomy
 
Caco-2 cell permeability assay for drug absorption
Caco-2 cell permeability assay for drug absorptionCaco-2 cell permeability assay for drug absorption
Caco-2 cell permeability assay for drug absorption
 
Biological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdfBiological Classification BioHack (3).pdf
Biological Classification BioHack (3).pdf
 
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxAnalytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
 
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow 💋 Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
 
A relative description on Sonoporation.pdf
A relative description on Sonoporation.pdfA relative description on Sonoporation.pdf
A relative description on Sonoporation.pdf
 
Isotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoIsotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on Io
 
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Munirka Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
 
The Philosophy of Science
The Philosophy of ScienceThe Philosophy of Science
The Philosophy of Science
 
Work, Energy and Power for class 10 ICSE Physics
Work, Energy and Power for class 10 ICSE PhysicsWork, Energy and Power for class 10 ICSE Physics
Work, Energy and Power for class 10 ICSE Physics
 

SARCOMA.pptx

  • 2. PRESENTED BY SWATI RAI M.Sc. NURSING 1st YEAR 6/6/2022 K.G.M.U (CON) SARCOMA 2
  • 3. OUTLINE 6/6/2022 K.G.M.U (CON) SARCOMA 3 After completion of the practice teaching the participants will be able to :  Introduction  Definition of Sarcoma  Incidence  Types of sarcoma  Etiology  Clinical manifestation
  • 4. Contd. 6/6/2022 K.G.M.U (CON) SARCOMA 4  Pathophysiology of sarcoma  Assessment and diagnostic evaluation  Medical management (Pharmacological and Non – Pharmacological)  Surgical management  Nursing management  Complications  Health education
  • 5. Q.1 WHAT IS CANCER ? Q.2 WORLD CANCER DAY IS CELEBRATED ON ? 6/6/2022 K.G.M.U (CON) SARCOMA 5
  • 6. INTRODUCTION 6/6/2022 K.G.M.U (CON) SARCOMA 6  SARCOMA – A rare type of cancer that grow in connective tissue like bones, nerves, muscles, and blood vessels of the arms and legs. It causes abdominal pain, lump, bone pain, and weight loss. Soft tissue sarcoma forms in the tissues that connect, support and surround other body structures.
  • 7. DEFINITION 6/6/2022 K.G.M.U (CON) SARCOMA 7  Sarcoma is a type of cancer that can occur in various locations in your body. Sarcoma is the general term for a broad group of cancers that begin in the bones also known as (soft tissue sarcoma).
  • 9. INCIDENCE 6/6/2022 K.G.M.U (CON) SARCOMA 9  The incidence for all ages is one case per 1 million people in the United States. In patients aged 10 to 19 years, the incidence is between nine and ten cases per 1 million people.
  • 10. TYPES OF CANCER 6/6/2022 K.G.M.U (CON) SARCOMA 10  Benign tumors- are slow growing tumors, well circumscribed, and encapusulated. They produce few symptoms . Benign primary neoplasms of musculoskeletal system.  Malignant benign tumor – primary malignant tumor are relatively rare and arise from connective tissues cells or bone marrow elements (myelomas).  Metastatic tumor – more common malignant bone tumor.the most common primary sites of tumors that metastasize to bone are kidney.
  • 12. ETIOLOGY 6/6/2022 K.G.M.U (CON) SARCOMA 12  Growth related : risk is highest for those between 10-30yrs of age .the risk goes down during in middle age but rises in older age of 60’s .  Somatic alterations : TP53 AND RB1 shows recurrent somatic alterations in concurrent studies .  Radiation therapy for cancer- Radiation treatment for cancer increases the risk of developing a sarcoma later.
  • 13. Contd. 6/6/2022 K.G.M.U (CON) SARCOMA 13  Exposure to chemicals. Certain chemicals, such as some industrial chemicals and herbicides, can increase the risk of sarcoma that affects the liver.  Exposure to viruses. The virus called humanherpesvirus 8 can increase the risk of a type of sarcoma called Kaposi's sarcoma in people with weakened immune systems.
  • 14. 6/6/2022 K.G.M.U (CON) SARCOMA 14  Germ line defect : The tumors is identified by the tissue of origin , the anatomic site, the behaviour the tumors(benign or malignant ).  EMBRYONAL ECTODERM - originates Carcinoma (skin and glands ).  ENDODERM – Mucus membrane linings of respiratory tract , GI , GU tract.  MESODERM –sarcoma(connective tissue, muscles, bone and fat ).  Lymphoma and leukemia are originated from HEMATOPOETIC SYSTEM . Contd.
  • 18. SIGN AND SYMPTOMS 6/6/2022 K.G.M.U (CON) SARCOMA 18  A lump that can be felt through the skin that may or may not be painful  Bone pain  Joint swelling and stiffness  Weight loss  Spinal metastasis resulting in cord compression and neurologic deficits, paresthesia, paraplegia .  Abdominal pain (due to abdominal metastasis and have poor prognosis)
  • 19. DIAGNOSTIC EVALUATION 6/6/2022 K.G.M.U (CON) SARCOMA 19  Collect the history upto 3rd gen. and perform a physical examination , may be diagnosed incidentally after pathologic fracture.  Inspection, palpation can be done to identify the lump or mass .  Perform ct scan , bone scans , myelography, MRI, and chest x ray.  Obtain biochemical assay of the blood to identify TP53 and RB1 gene .  Alkaline phosphate levels are frequently elevated with osteogenic sarcoma , serum acid phosphate levels are elevated with metastasis in liver .
  • 20. 6/6/2022 K.G.M.U (CON) SARCOMA 20  Arteriography – to assess the soft tissue involvement. x-ray examination of an artery or arteries following injection of a radiopaque substance.{Barium sulfate and organic iodides} are commonly used .  Improve the image contrast (radiocontrast) and visibility of relevant anatomic loci.
  • 21. 6/6/2022 K.G.M.U (CON) SARCOMA 21  Perform surgical biopsy for histologic identification , staging, based on tumor size, grade ,location and metastasis. (TNM classification )  BIOPSY :  FINE NEEDLE ASPIRATION CYTOLOGY (FNAC )  CORE NEDDLE ASPIRATION (CNA)
  • 24. CHEMOTHERAPY 6/6/2022 K.G.M.U (CON) SARCOMA 24  Chemotherapy is started before and continued after surgery in an effort to eradicate micrometastatic lesions.  Drugs : MAID REGIMEN [ Mesna, Adriyamycin(doxorubicin), Ifofosfamide and Dacarbazine]  AID RGIMEN- Adriyamycin, Ifofosfamide , Mesna
  • 25. SURGICAL MANAGEMENT 6/6/2022 K.G.M.U (CON) SARCOMA 25  LIMB SALVAGE : – involves resection, of affected bone , muscle and normal muscle tissue and reconstruction using metallic prosthesis or allografts for bone or joint replacement and skin grafting as needed.
  • 26. 6/6/2022 K.G.M.U (CON) SARCOMA 26  Radiation is energy that is emitted from a source and travels through space or some material .  Delivery of high- energy beams when absorbed into tissue ,produces ionization radiation act to break the chemical bond in DNA .  The DNA is damaged, resulting in cell death .  TYPES OF IONIZING RADIATION RADIATION THERAPY 1. Electromagnetic radiation i.e ( x - ray , gamma ray ) 2.Particulate radiation (alpha particles,electrons, neutrons, protons) 3.High – energy - x rays (photons)
  • 28. COMPLICATIONS 6/6/2022 K.G.M.U (CON) SARCOMA 28  Metastasis.  Pathologic fracture  Hypercalcemia from bone destruction
  • 29. NURSING MANAGEMENT 6/6/2022 K.G.M.U (CON) SARCOMA 29 ASSESSMENT  Obtain the health history of progression of disease , presence of pain ,fever ,weight loss and malaise .  Examine for painless mass .  Review records for evidence of pathologic fractures .  Asses knowledge of cancer experiences with family , others, and present coping .
  • 30. NURSING DIAGNOSIS 6/6/2022 K.G.M.U (CON) SARCOMA 30 1. Acute pain related to effects of tumors . 2. Risk for injury related to altered bone structure 3. Ineffective coping related to diagnosis and treatment options. 4. Altered Nutrition: Less Than Body Requirements related to hypermetabolic state associated with cancer/Consequences of chemotherapy, radiation, surgery, e.g., anorexia, 5. Risk for Infection related to Inadequate secondary defences and immuno suppression, e.g., bone marrow suppression
  • 31. NURSING INTERVENTION 6/6/2022 K.G.M.U (CON) SARCOMA 31  Acute pain related to effects of tumors  Use multiple approaches to reduce discomfort  Administer pain medication 30 minutes before ambulation or other uncomfortable movement .  Support painful extrimities on pillows.  Risk for injury related to altered bone structure  Assist patients in movement with gentleness and patience  Avoid jarring patients and bed .  Supports joints when repositioning patients.
  • 32. 6/6/2022 K.G.M.U (CON) SARCOMA 32  Guard patients to avoid falls raise the side rails .  Create a hazard –free environment .  Provide patients education on safety and ambulation  Ineffective coping related to diagnosis and treatment options.  Create a supportive environment  Answer questions and clear up misconceptions about treatment options .  Use pshychological support services as nedded
  • 33. PATIENT EDUCATION AND HEALTH MAINTENANCE 6/6/2022 K.G.M.U (CON) SARCOMA 33  Teach about particular treatment selected .  Encourage appropriate follow up and diagnostic testing for recurrence.  Refer for additional information and support to the American cancer society .
  • 34. PROGNOSIS 6/6/2022 K.G.M.U (CON) SARCOMA 34  Using the SEER database, statistics show that people with a soft tissue sarcoma have an average 5-year survival rate of 65%.  Sarcoma life expectancy depends on factors such as the tumor’s type, size, location, rapidity of tumor cell growth, and where it is located when first diagnosed.  The National Cancer Institute reports 5-year survival data for cancer from the SEER (Surveillance, Epidemiology and End Results) database, based on whether the cancer was found when it hadn’t yet spread (localized) .
  • 36. RECAPTUALIZATION 6/6/2022 K.G.M.U (CON) SARCOMA 36 1. Which one of the following soft tissue sarcomas frequently metastasizes to lymph nodes? A. Fibrosarcoma B. Alveolar soft part sarcoma C. Osteosarcoma D. Embryonal Rhabdomyosarcoma Answer - D 2. Which type of cancer is sarcoma ? A. A sarcoma is same as carcinoma but is benign B. A sarcoma is a cancer that develops from tissue like the muscle . C. A sarcoma is a type of cancer that does not spread to other sites. D. A sarcoma affects only children while a carcinoma affect only adults Answer - B
  • 37. 6/6/2022 K.G.M.U (CON) SARCOMA 37 3. A sarcoma that arise from fat tissue is called – A. Fibrosarcoma B. Liposarcoma C. Leimyosarcoma D. Rhabdomyosarcoma Answer - B 4. Osteosarcoma arise from the A. Muscle B. Bone C. Blood vessels D. Nerves Answer - B
  • 38. ASSIGNMENT 6/6/2022 K.G.M.U (CON) SARCOMA 38  Write a short note on sarcoma and its management ?  Date of submission : 07/06/2022